Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Caprelsa

(ka-PREL-suh)
A drug used to treat medullary thyroid cancer that is locally advanced and cannot be removed by surgery or has spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Caprelsa blocks certain proteins, which may help keep cancer cells from growing. It may also prevent the growth of new blood vessels that tumors need to grow. Caprelsa is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called vandetanib and ZD6474.
Search NCI's Dictionary of Cancer Terms